Jia Jie Biomedical Co Ltd Asset Resilience Ratio
Jia Jie Biomedical Co Ltd asset resilience ratio. Jia Jie Biomedical Co Ltd (4109) has an Asset Resilience Ratio of 13.01% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 4109 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Jia Jie Biomedical Co Ltd (2015–2025)
Asset resilience ratio of Jia Jie Biomedical Co Ltd from 2015 to 2025. This chart shows how Jia Jie Biomedical Co Ltd's Asset Resilience Ratio has changed over time. Read Jia Jie Biomedical Co Ltd (4109) financial obligations for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Jia Jie Biomedical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Jia Jie Biomedical Co Ltd total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 0% |
| Short-term Investments | NT$250.06 Million | 13.01% |
| Total Liquid Assets | NT$250.06 Million | 13.01% |
Asset Resilience Insights
- Moderate Liquidity: Jia Jie Biomedical Co Ltd has 13.01% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
Jia Jie Biomedical Co Ltd Industry Peers by Asset Resilience Ratio
Compare Jia Jie Biomedical Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
The Magnum Ice Cream Company N.V.
AS:MICC |
Packaged Foods | 0.11% |
|
Unibel S.A
PA:UNBL |
Packaged Foods | 0.24% |
|
JiangXi Tianxin Pharm Co Ltd
SHG:603235 |
Packaged Foods | 4.40% |
|
Sanquan Food Co Ltd
SHE:002216 |
Packaged Foods | 13.01% |
|
JinJian Cereals Industry Co Ltd
SHG:600127 |
Packaged Foods | 0.04% |
|
Beijing Sanyuan Foods Co Ltd
SHG:600429 |
Packaged Foods | 0.10% |
|
Kri-Kri Milk Industry S.A
AT:KRI |
Packaged Foods | 1.34% |
|
Ridley Corporation Ltd
AU:RIC |
Packaged Foods | 0.27% |
Jia Jie Biomedical Co Ltd Asset Resilience Ratio by Year (2015–2025)
Jia Jie Biomedical Co Ltd asset resilience ratio by year from 2015 to 2025. The table below shows the annual Asset Resilience Ratio data for Jia Jie Biomedical Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 9.80% | NT$185.09 Million ≈ $5.83 Million |
NT$1.89 Billion ≈ $59.51 Million |
-0.33pp |
| 2024-12-31 | 10.13% | NT$150.11 Million ≈ $4.73 Million |
NT$1.48 Billion ≈ $46.70 Million |
+8.02pp |
| 2023-12-31 | 2.11% | NT$29.74 Million ≈ $937.04K |
NT$1.41 Billion ≈ $44.51 Million |
-10.67pp |
| 2022-12-31 | 12.77% | NT$128.21 Million ≈ $4.04 Million |
NT$1.00 Billion ≈ $31.63 Million |
+1.61pp |
| 2021-12-31 | 11.16% | NT$114.03 Million ≈ $3.59 Million |
NT$1.02 Billion ≈ $32.18 Million |
-0.92pp |
| 2018-12-31 | 12.09% | NT$135.21 Million ≈ $4.26 Million |
NT$1.12 Billion ≈ $35.24 Million |
+8.24pp |
| 2017-12-31 | 3.85% | NT$50.88 Million ≈ $1.60 Million |
NT$1.32 Billion ≈ $41.62 Million |
+2.47pp |
| 2016-12-31 | 1.38% | NT$22.68 Million ≈ $714.54K |
NT$1.65 Billion ≈ $51.90 Million |
+0.63pp |
| 2015-12-31 | 0.74% | NT$11.74 Million ≈ $369.87K |
NT$1.58 Billion ≈ $49.75 Million |
-- |
About Jia Jie Biomedical Co Ltd
Jia Jie Biomedical Co., Ltd. produces and sells health foods in Taiwan and Mainland China. It operates through two segments: Nutritional Health Products and Insurance Brokerage. The company engages in the processing, sale, and trading of softshell turtle food; manufacture of dairy products; miscellaneous food manufacturing, such as softshell turtle egg powder capsules, enzyme powder, tortoise jel… Read more